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Individuals who are diagnosed with Type II Diabetes Mellitus (T2DM) have 
shown decline in proper kidney function, ultimately leading to a form of chronic kidney 
disease (CKD) in about one- third of T2DM cases. Even though these are alarming rates 
of both diseases, these conditions are rarely studied concurrently. The general focus for 
this research is to identify whether or not kidney function in individuals with T2DM 
relates to their cognitive function. Specifically, is albuminuria in individuals with T2DM 
a risk for poorer cognitive performance? Maine Syracuse Longitudinal Study (MSLS) 
data for the 121 participants with T2DM was analyzed through correlational analysis and 
a series of hierarchical multiple regression analyses. Data analysis showed no evidence to 
support albuminuria as a risk factor for cognitive decline in T2DM. Evidence was found 
to support GFR as a risk factor for working memory and executive function decline.   
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Roughly 7%, 23 million, United States residents are diagnosed with Type II 
Diabetes Mellitus (T2DM). About 40,000 of those diagnosed lose their battle each year 
(“Diabetes Statistics”, n.d.). According to the National Institutes of Health, kidney 
disease is another illness that has a considerable prevalence of about 30 million people in 
the United States (“Kidney disease statistics for the United States”, n.d.). Individuals who 
are diagnosed with T2DM have shown decline in proper kidney function, ultimately 
leading to a form of chronic kidney disease (CKD). In most cases, CKD is a result of 
poorly managed diabetes (Rowley et al. 2017 and “Diabetic Kidney Disease”, n.d.). 
Approximately one-third of those diagnosed with T2DM also have a form of kidney 
disease (“Diabetic Kidney Disease,” n.d.). Even though these are alarming rates of both 
diabetes and kidney disease, these conditions are rarely studied concurrently. Based on 
the correlation between the two illnesses,  CKD and T2DM should be researched in 
conjunction with one another to further our understanding of both conditions.  
 
Importance 
Many different illnesses take a toll on the cognitive ability of the human brain, 
however there is a gap in some research on the specific disease processes that cause these 
cognitive deficits. Therefore, it is important to keep researching different organ systems 
and how they impact brain health. Organs such as the kidneys and pancreas are very 
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important to keep the body functioning, but the brain is what makes a person an 
individual through cognitive processes, making it a very significant subject to research. 
Although this thesis will focus primarily on the organ systems that contain the 
kidney and the brain, it is important to note at the outset that cognitive performance is 
best addressed from a comprehensive perspective that includes  psychological and 
sociocultural systems. A biopsychosocial approach is useful in medical research because 
it combines three natural influences and helps us to conceptualize how issues occur, 
leading to preventive care. The sections that follow provide background information on 
the focal organ systems and variables used to index other relevant systems featured in this 
study.  
 
Kidney Structure and Function 
Kidneys are composed of about one million nephrons which are functional units 
of the kidneys. Nephrons consist of a tubule in the outer layer of the kidney and they 
eventually empty into the ureter. The tubule begins with the bowman’s capsule, where 
water and solutes enter the nephron from the blood (filtration). The water and solutes 
then move to the proximal tubule in the outer cortex of the kidney which is the 
reabsorption site. Then, the tubule goes into the loop of Henle which passes through the 
center of the kidney and back (cortex). The loop of Henle is for reabsorption of more 
solutes than water. Then, the fluids go through the distal tubule (cortex) and are utilized 
for reabsorption and secretion to maintain homeostasis. Then with the collecting duct, 
multiple tubules join and descend to the ureter to empty into the bladder. The collecting 
duct also serves as a last stop for reabsorption of water (Radi et al., 2019). 
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In the human body, the kidneys consist of two organs on either side of the 
retroperitoneal space behind the abdomen. Waste excretion (filtration), regulation of pH, 
osmolarity, ion concentration, and secretion of hormones are just some of the functions 
kidneys are utilized for. The kidneys are responsible for maintaining water and 
electrolyte balance (homeostasis) in the body (“What is Chronic Kidney Disease?,” n.d.). 
 
Biomarkers of Proper Kidney Function 
Kidney function is measured through biomarker testing. A biomarker is defined as 
a detectable molecule that is present in specific functions. Biomarker testing has become 
more popular in recent years. By using blood and urine biomarkers in conjunction, the 
area of concern can be discovered in the nephron and be determined if it is a structural or 
functional issue (Menez et al., 2019). The three biomarkers of normal kidney function are 
glomerular filtration rate, creatinine, and albumin. Glomerular filtration rate (GFR) and 
creatinine is a blood test to see if the kidneys are working properly and is common in 
routine testing. GFR is generally estimated through creatinine levels. Creatinine is a 
waste product that comes from the blood and is excreted through the kidneys. Thus, the 
more creatinine in the blood, the less is excreted, indicating poor renal function. GFR is 
dependent on creatinine because it measures how creatinine is filtered out. Albumin is a 
protein in the liver that functions to keep fluids in the bloodstream and not allow fluids to 
leak into surrounding tissues (Albuminuria). It can also transport hormones and vitamins 
throughout the body and has been associated with insulin resistance (Bae et al., 2013). 
Detection of albumin in the kidneys can indicate insufficient blood flow to the brain 
(“What is albuminuria”, n.d.).  
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Albumin. Albumin, the least researched biomarker of kidney function, is one of 
the major proteins synthesized in the liver. Its involvement in the bloodstream is crucial 
to transport necessary hormones and fluids around the body. Reduced levels of serum 
albumin is linked to malnutrition, risk of coronary  artery disease, and cardiovascular 
issues. On the other hand, elevated albumin levels are associated with metabolic 
syndrome and obesity. As mentioned prior, insulin resistance is linked to the 
development of diabetes mellitus. That association may occur through oxidative stress 
and chronic inflammation which can adversely affect albumin, leading to insulin 
resistance (Bae et al., 2013).  
Biomarker Levels.  For GFR, the normal range is anything above 60 mL/min. A 
result below 60 mL/min can suggest kidney disease while anything below 15 mL/min is 
considered renal failure (“Explaining your kidney test results: A tool for clinical use.”, 
n.d.) Creatinine levels vary depending on the weight and muscle mass of the individual. 
For the average adult woman a normal creatinine range is 0.6 to 1.1 mg/dL and the 
average adult male has a range of 0.9 to 1.3 mg/dL. If the test yields results higher than 
the normal range then kidney disease, diabetes, or heart failure may be the cause. If the 
values are low, liver failure is the most common cause (“Creatinine (Blood)”, n.d.). GFR 
is determine through a formula that controls for age, gender, ethnicity, and creatinine 









𝑆!" is serum creatinine level, 𝑘 is 0.7 for females and 0.9 for males, and	𝑎 is -
0.329 for females and -0.411 for males (Estimating glomerular filtration rate, n.d.).  
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Serum albumin is measured through a blood test and normal results yield 3.4 to 
5.4 g/dL, and an albumin urine test result of any amount of albumin below 30 mg/g is 
within normal limits (“Albumin (Blood”), n.d., & “What is albuminuria”, n.d.). 
Albuminuria is when albumin detected is above the normal range, meaning there is an 




Glucose enters the body through carbohydrates in food. It travels through blood to 
cells that require it for energy. Thus, glucose is what gives the body energy and is 
regulated by the hormone insulin. Insulin is involved in transporting glucose in and out of 
cells. When there is an increase or decrease of blood glucose, issues occur. 
Hyperglycemia, increase of blood glucose levels, is caused by type I and type II diabetes 
mellitus. Altered mental status, excessive urination, dehydration, orthostatic hypotension, 
and motor coordination issues are responses that can  occur from some hyperglycemia 
cases because of the high plasma osmolarity it causes. On the other hand, hypoglycemia 
is when there are low blood glucose levels. Usually caused by fasting or excessive 
exercise, hypoglycemia can lead to coma, loss of consciousness, altered mental status, 
and anxiety (McMillin et al., 1990; Hantzidiamantis et al., 2020).  
 
Insulin Resistance. Insulin resistance in diabetics and non-diabetics is detrimental 
to physical health. Hypertension, oxidative stress, chronic inflammation, dyslipidemia 
and, if not already diagnosed, T2DM are a result from insulin resistance (Kosmas et al., 
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2018). Nonetheless, T2DM individuals are more at risk for health deficits because insulin 
resistance is a leading cause of their lower cognitive performance (Stanford, 2014). 
Imbalance in the glucose metabolism is what turns insulin resistance into T2DM. The 
decrease in insulin response to glucose uptake targets the sensitive tissues of skeletal 
muscle and adipose tissue, leaning towards chronic inflammation (Kosmas et al., 2018).  
 
Insulin Resistance and Comorbidities. CKD is categorized as an insulin resistance 
state where their risk for developing cardiovascular disease increases to almost 100% 
(Kosmas et al., 2018). When someone has unknown hypertension or does not properly 
treat it, insulin resistance is typically the outcome if not the cause. That is due to the 
impaired glucose uptake because hypertension disturbs the delivery of insulin and 
glucose to skeletal muscles. Vasoconstriction and activation of the sympathetic nervous 
system  is also a major contributor to the development of cardiovascular disease because 
it results in structural changes and increase of fast twitch fibers (Salvetti et al., 1993). 
Cholesterol is another risk factor for cardiovascular disease that has a role with insulin 
resistance. Insulin resistance increases cholesterol synthesis and decreases cholesterol 
absorption (Gylling et al., 2010).  
 
Diabetes Mellitus: Type I and II 
Type I Diabetes Mellitus is generally diagnosed in adolescence or soon after. 
There is an issue with how the body produces insulin, so issues with blood glucose arise. 
The immune system attacks the pancreas and the cells that create insulin so the body 
stops producing it. Without the hormone insulin, glucose in the blood is not regulated and 
 
 7 
leaves the body in a hyperglycemic state. To prevent this, insulin is taken regularly by 
those diagnosed. T2DM is when blood glucose is too high because there is not enough 
insulin in the body, or improper function of insulin. Insulin resistance is a leading cause 
of T2DM. Diet is a huge factor in blood glucose levels. The majority of those diagnosed 
with the condition are overweight or obese (Rowley et al., 2017).  
 
Pre-Diabetes. The majority of individuals who are diagnosed with T2DM had a 
period of time prior to the diagnosis considered a “pre-diabetic” stage. During that time, 
there are hints of kidney disease from their biomarker levels. Usually that is detected by a 
slightly higher than 60 mL/min GFR test and slightly elevated creatinine. Albumin 
testing is not common in routine testing, but because of the abnormal results of creatinine 
and GFR, albumin would be the next step for proper diagnosis of diabetes or kidney 
disease. Early detection of pre-diabetes tends to slow the progression of T2DM which 
contributes to the popularity of biomarker testing (Dabla., 2010).  
 
Cognition 
Cognition refers to thinking processes, such as the ability to remember, think, and 
learn and is important for performing everyday tasks. Cognitive decline refers to a 
decrease in previous levels of functioning. Functional ability refers to the ability to 
perform everyday tasks (“Cognitive Health and Older Adults,” n.d.). Examples of 
cognitive disorders are cognitive decline or impairment, vascular dementia, Alzheimer's 
disease, Huntington’s disease, Parkinson’s disease, and aphasia (Vascular dementia and 




 Cognitive domains are the various types of cognitive functions (Harvey, 2019).  
 
Attention.  Attention refers to how an individual responds to and processes certain 
stimuli. An individual can have different attentional capacities to certain stimuli, and 
capacities differ from person to person. Attention can be altered from one stimulus to 
another, whether focused or selective, and is commonly known as concentration. The 
time a person can maintain concentration is referred to their sustained attention. If 
concentration can be split between different stimuli, it is considered divided. The most 
common mental issues associated with brain damage are issues with attention and 
concentration (Leclercq, Deloche, and Rousseaux, 2002;  Lezak, 1995).  
 
Working Memory. Working Memory holds information for a short period of time. 
Some researchers suggest that there are two subsets of working memory; language and 
visuospatial skills. Working memory is an extremely important memory system to have 
working properly since it aids in internalizing information and guiding behavior without 
the need for clues. Language is useful for working memory because of the phonological 
loop. Processing the words we hear and being able to repeat them aloud is helpful for 
retaining the information.  
 
Learning and Memory. Memory is the process of encoding, storing, and retrieving 
information. There are multiple types of memory such as sensory, short term, and long 
term memory and different memory systems such as declarative and nondeclarative. Each 
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category is uniquely different and holds and encodes different amounts of information 
(Zlotnik et al., 2019). Learning is broadly defined as changes in behavior as a result of 
experience in the organism’s environment. A person remembers an experience and uses 
that to react to other situations or for higher order processing such as abstraction (De 
Houwer et al., 2013).  
 
The Declarative Memory System. The declarative memory system is divided into 
semantic and episodic memory.  Semantic refers to fact based knowledge while episodic 
refers to the memory of individual-specific experiences, also known as autobiographical 
memory. Therefore requiring this memory system to be the ability to learn and remember 
information (Lezak, 1995).  
 
The Nondeclarative Memory System. The nondeclarative memory system 
consists primarily of implicit memory. Nondeclarative memory involves unconscious 
remembering (i.e., buttoning a shirt). This mostly includes reactions to previous 
experiences and remembering how you felt towards them. This differs from episodic 
memory since it is not recalling the specific events of the situation, but the unconscious 
thoughts and reaction to it (Lezak, 1995). 
 
 Sensory memory. Sensory memory includes the information that is encountered 
throughout everyday life. It is what is captured through the senses: sight, taste, hearing, 




 Short-term memory. Short-term memory is a step above sensory memory in 
regard to storage. It holds on to a small amount of information, but not for an extended 
period of time. Sensory memories that are processed are moved onto short-term to be 
encoded by working memory. Short-term memory is extremely important because it 
allows for learning, reasoning, and understanding to occur because our memories can 
change based on new information. Retrieval and rehearsing information is useful to 
ensure that it can be processed and held onto in long-term memory from short- term 
memory. Overall, short-term memory is a temporary storage unit for learned information 
(Camina et al., 2017).  
 
 Long-term memory. Long-term memory is essentially unlimited. It is where 
information can get recalled and hold unconscious and conscious information encoded by 
short-term memory (Camina et al., 2017). The mechanisms of long-term memory are 
more at the molecular and cellular level than other parts of the brain. Neurochemical 
alterations at the synapse and neurons account for the differences in amount of 
neurotransmitters released or reuptaken when remembering long-term stored information. 
There is not one part of the brain responsible for long-term memory (Lezak, 1995).  
 
Language. This is the ability to understand, process, and produce verbal functions. 
Learning and memory are major contributors to language since recall is needed to 
remember the name of an object that you once learned about. Typically, material learned 
in childhood (i,e., alphabet, numbers, months) that is repeated throughout life is known as 
automatism. In order to test for issues with language acquisition, word list learning tests 
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are typically used since this engages short-term memory and learning capacities. That is, 
immediate recall testing is insufficient because many older people (typical cognitive 
study participants) do have the same immediate memory span as young adults. Thus, 
simple tests such as digit sequence learning are inadequate (Lezak, 1995).  
 
Visuospatial Skills. Visuospatial skills is defined as the ability to imagine and 
visualize objects and identify differences between similar objects. It is how we visually 
interact with the world (Possin, 2010). Visuospatial skills use working memory to 
visually remember an experience and play it back to complete different tasks and actions 
(Valler et al., 2002). Drawing construct objects such as trees or flowers is an example of 
a visuospatial skill (Mervis et al., 1999). Impairment in visuospatial skills are one of the 
first symptoms in neurodegenerative diseases (Possin, 2010).   
 
Executive Function. This domain encompasses the several higher-order processes 
involved in planning, monitoring, and implementing complex, multi-step tasks. Executive 
function is broadly defined with various definitions, but core functions include set-
shifting (unconscious switching of attention between tasks), response inhibition 
(suppressing inappropriate actions), planning and problem-solving (Mostofsky et al., 
2008). If executive function is lost, it is more obvious to notice cognitive function 
deteriorating since they have issues socially and completing tasks that were natural to 
them prior. Usually, family members and friends are the first to notice.  However, if there 
is cognitive decline but executive function is intact, there can be a considerable amount 
of impairment until daily functioning is disrupted (Lezak, 1982) 
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Emotion. Emotion is a conscious awareness of a mood perceived from an 
experience. There are seven emotions: anger, disgust, contempt, happiness, sadness, 
surprise, and fear. Memory, attention, reasoning, learning, abstraction, and perception are 
all influenced by emotion. It can serve as a motivator for motor functions as well. 
Typically, physical and behavioral changes are a response to a change of emotion (Lezak, 
1995).  
 
Abstraction and Reasoning. Abstraction is a distinct characteristic of human 
beings. It is the ability to concentrate and reason on a higher level without the need for 
concrete information. For example, interpreting statistical results uses abstraction (“On 
the cognitive process of abstraction,” 2016).  
 
Processing Speed. Processing speed refers to the time it takes to complete a 
mental task. It is dependent on attention, memory, language, and visuospatial skills. A 
slower processing speed is common in older adults, diagnosed autism, injury, or 
cognitive decline or impairment (Holdnack et al., 2016). However, the processing speed 
decline in older adults is not the same as impaired processing speed from injuries or 
neurological disorders. For healthy adults, the processing ability is still there, but the 
performance is poorer. While for injuries or neurological disorders, there is a mechanism 
that is not functioning correctly, leading to the slower processing speed.  
 
Motor Function.  Motor function and coordination occurs anterior to the 
precentral area in the brain (Damasio et al., 2003; Eslinger et al., 2001; Kolb et al., 1996). 
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Damage to that area results in incoordination, strength, or discontinuous movements, but 
does not completely inhibit the motor action from occurring (Jason., 1990; Mesulam., 
2000). Motor function can be separated into fine and gross functions. Gross motor 
function implies a large muscle group working to complete a task (i.e. walking) while 
fine motor movement involves small muscle groups (i.e. writing with a pencil).  
 
Theories of Cognitive Aging 
 The brain has been shown to change structurally and functionally as it ages. The 
connectivity between the anatomical structures of the brain is recorded to decrease 
throughout the years, resulting in changes to functional connectivity which relates to 
cognitive decline. Those alterations have been shown to decline linearly in regard to the 
number of connections and total fiber count (Betzel et al., 2014). Research has shown 
that brain function is dependent on the path length and connected nodes. The increase 
in  neural pathways leads to the increases in connectivity between structures.. In older 
adults, there fewer are higher order connections between networks than compared to 
younger adults (Betzel et al., 2014).  The loss of some connected networks or reduced 
white matter integrity is also a result of cognitive decline from aging (Krechner et al., 
2012).   
 The hemispheric asymmetry reduction in older adults (HAROLD) model of 
cognitive aging states that cognitive performance is less lateralized in older adults than 
younger adults, reorganizing functional ability when needed. Neural networks and 
circuits are developed to create more pathways of function to complete given cognitive 
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tasks. Episodic, semantic, and working memory are the cognitive domains that are 
highlighted in the HAROLD model (Cabeza, 2002). 
Another theory of cognitive aging is known as the Compensation-Related 
Utilization of Neural Circuits Hypothesis (CRUNCH) model. This model is 
complementary to the HAROLD model. That hypothesis suggests that as a person ages, 
more neural circuits are needed to complete a task compared to a younger adult. That was 
supported by areas of the brain being activated during a task in older adults and not in 
younger adults. This finding leads to the conclusion that older brains function differently 
than younger ones. Those active sites are also considered to be overactivating or 
compensating more than they should in order to complete the tasks due to cognitive 
decline (Reuter-Lorenz et al., 2008). 
 The scaffolding theory of aging (STAC) is similar to the CRUNCH model. They 
both suggest that as the brain ages, it begins to function differently. Scaffolding, which is 
present  throughout life, is the creation of alternative neural circuits to complete a 
cognitive task. Research suggests that without the development of new neural 
connections, the brain will decline more rapidly and deteriorate, but it is strengthened by 
cognitive engagement and exercise (Park et al., 2009). 
 
Lifestyle Factors and Cognition 
 
Mediterranean Diet 
The Mediterranean Diet (MedDiet) has recently gained popularity in the last 20 
years due to the health benefits it provides (Lăcătușu et al., 2019). In the 1960s, the 
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MedDiet was first defined and practiced in Greece and Italy mostl, giving the diet it’s 
name since those countries are off of the Mediterranean Sea (Davis et al., 2015 & 
Lăcătușu et al., 2019). The MedDiet mainly consists of vegetables, legumes, nuts, seeds 
and fruits with olive oil being the main fat and seafood being moderately consumed. 
Dairy and alcohol are also not prohibited, but are not a focal point in the diet (Lăcătușu et 
al., 2019).  
 
Health Benefits of the Mediterranean Diet. Ancel Keys was the first to 
acknowledge the importance of the Mediterranean diet. He was studying starvation’s 
effect on the human body after World War II and noticed that places that had diets that 
did not follow the typical high-fat and high-protein standards had significantly less heart 
issues. Famine may have been the cause for the switch in diets, but it was evident that the 
diet was effective for avoiding cardiovascular casualties because places without a famine 
did not show a difference from before the war (Lăcătușu et al., 2019).  
 The Seven Countries Study was created by Keys to investigate his observation 
and produce a cause- effect relationship. When followed, MedDiet showed that there was 
a decreased risk in developing cardiovascular disease (Lăcătușu et al., 2019).  
 
Cognitive Health Benefits of the Mediterranean Diet. Besides the cardiovascular 
health benefits, researchers suggest that when an individual commits to a strict following 
to the MedDiet, they are less susceptible to cognitive issues and decline at a lower pace 
compared to individuals who do not follow the diet. There are also claims that the 
MedDiet can improve cognitive performance over time (Féart et al., 2010). The cereals, 
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dietary antioxidants, wine, and macronutrients involved in the MedDiet are the most 
protective against cognitive decline (Panza et al., 2004).   
 
Mediterranean Diet and Kidney Function. The MedDiet was shown to be 
associated with kidney function and those who followed it had reduced eGFR compared 
to those who did not follow the diet. Yielding that the diet is protective over the kidneys 
and can be beneficial for CKD patients as well in terms of survival (Khatri et al., 2014 & 
). However, due to the recent discovery of the MedDiet, there is not much research on its 
impact outside of cardiovascular health. Therefore, the research done in this study will 
hopefully help shed light on the impact on MedDiet on CKD and T2DM.  
 
Mediterranean Diet and Type II Diabetes. Adhering to a MedDiet has been shown 
to lower the risk of developing T2DM by about 20% compared to other diets such as 
DASH. The American Diabetes Association described the MedDiet as beneficial because 
it also promotes an overall healthy lifestyle which reduces the risk of hypertension, a risk 
factor for T2DM (Martín-Peláez et al., 2020). 
 
Physical Activity 
A healthy diet is not the only factor that controls physical health, physical activity 
and exercise is crucial for staying healthy. Better performance is shown on cognitive 
testing from individuals who intentionally make exercise a part of their daily routine than 
those who do not (Clare et al., 2003). Besides physical health, exercise and physical 
activity has been shown to alleviate many mental health issues. Low self esteem, anti-
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socialism, and insomnia are some of the most common issues that seem to resolve once 
exercise is incorporated into daily life (Sharma et al., 2006). 
 
Socioeconomic Status  
Education. Less education is related to earlier and more severe cognitive decline. 
Higher education has shown to hold a positive correlation with cognitive function 
compared to individuals with less education when doing activities (Park et al., 2018). One 
theory that a lot of researchers support is that higher education leads to better health 
choices. For example, more education on physical health (i.e. doctors and nurses) may 
lead to better eating and exercise habits which ultimately lead to better brain health. 
Higher education may also hide mild cognitive deficits more easily than those without 
higher education (Lee et al., 2003).   
 
Household Income. Lower income has been associated with numerous mental 
health issues. When exposed to low income for over twenty years, the effects can be 
detrimental and irreversible. For example, lower income is related to higher levels of 
stress which can heavily impact physical health which leads to further cognitive issues. 
Evidence suggests that processing speed is the cognitive measure that is the most 
impacted by low income (Zeki AlHazzouri et al., 2016).  
 
Social Activity. Relationships and social activity are beneficial for slowing or 
preventing cognitive decline. Support, control, and comfort of others reduces stress and 
reduces physical health issues (Umberson et al., 2010).  
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Cognitive Performance with Type II Diabetes 
Per multiple literature review articles, cognitive measures of recall, trail making, 
word associations, and sequencing were the areas where the differences between patients 
with CKD or T2DM scored lower compared to their controls (Li et al. 2018., Passos et 
al., 2018, Pei et al., 2018, Sacre et al., 2019, & Småbrekke et al, 2019).With insulin 
resistance, metabolic syndrome and cardiovascular disease follow along with the 
development of T2DM (Kendall et al., 2002). Researchers suggest that the metabolic and 
vascular issues that arise with T2DM is the source for cognitive decline in that 
community (Karvani et al., 2019). Hypertension, insulin resistance, vascular 
inflammation, lipid disorders, hypoglycemia and hyperglycemia are examples of 
metabolic and vascular issues that can result from T2DM. Glucose intolerance is a direct 
result from insulin resistance, impairing glucose uptake in the body, leading to more 
metabolic issues such as obesity. (Kendall et al., 2002, Zilliox et al., 2016 ). In patients 
with and without diabetes comorbid with cardiovascular disease, insulin resistance is 
related to their lower cognitive performance and cognitive decline (Lutski et al., 2017). 
 
Cognitive Performance with Kidney Disease  
Chronic Kidney Disease is a high risk factor for lowered cognitive performance. 
The decline in cognition is more apparent in those with end-stage renal disease. 
Cerebrovascular disease is also more apparent in those with CKD which can increase 
cognitive decline. (Torres et al., 2017). Although cognitive deficits can prompt dementia, 
CKD often leads to a mild form of decline (Elias et al., 2013). Diminished white matter 
integrity in CKD patients promotes cognitive decline.  
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Cognitive Performance with Type II Diabetes and Kidney Disease  
Zhang and colleagues (2016) investigated kidney function in a T2DM sample 
with known cognitive impairment and discovered that elevated albumin and creatinine 
levels in urine were higher in those with cognitive impairment compared to those without 
(Zhang et al., 2016). In the cognitive domains of processing speed, memory, attention and 
executive function, participants with diagnosed T2DM performed less well. Also, they 
showed brain atrophy, lower total white and gray matter compared to non-diabetics 
(Moheet et al., 2015).  
 
Mechanisms Proposed for Associations 
One area for which research on T2DM and CKD comorbidity is important is with 
regard to cognitive performance. Therefore, the brain, where cognitive processing occurs 
will be included in the focus of this research. Because of the T2DM and CKD prevalence, 
it is important to emphasize the significance those conditions have on the human brain. 
When the kidneys and the brain are initially considered, they may not necessarily seem 
complementary, but evidence suggests a direct relationship (Sacre et al., 2019). When 
one of these organ systems is damaged, multiple organ dysfunction syndrome occurs 
leaving detrimental effects on the human body. Adverse reactions from damage highly 
target the hippocampus because of alterations to the blood brain barrier from ischemic 
renal injury or CKD (Malek, 2018). Albuminuria has also been correlated to the 
breakdown of the blood brain barrier (Burns et al., 2018). Dementia diagnoses are 
increased in the CKD population compared to those without any stage of kidney disease 
(Dotiwala et al., 2020).  
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The blood-brain-barrier is a tight boundary made of endothelial cells , 
membranes, and astrocytes that keeps the fluid of the brain in the brain while keeping out 
cerebral capillary blood and while regulating the cerebrospinal fluid. Due to its anatomy, 
only select molecules can advance through the tight junctions between the cells. 
However, damage can weaken the barrier and allow for unwanted molecules to pass 
through and damage the brain (Dotiwala et al., 2020).  
In addition to T2DM, CKD is known to have a negative effect on cognitive 
performance (Torres et al., 2017). Torres (2017) states that chronic kidney disease is a 
high risk factor for lower cognitive performance compared to those without chronic 
kidney disease and is more apparent in individuals with end stage renal disease (ESRD) 
(Torres et al., 2017). However, not all stages of kidney disease and all those diagnosed 
with T2DM show decline on cognitive testing. Typically, those who are diagnosed with 
either illness, CKD and T2DM,  perform worse on memory, processing speed and recall 
cognitive testing compared to their undiagnosed counterparts. Some researchers attribute 
the cognitive decline in T2DM to insulin resistance and metabolic syndrome (Bae et al., 
2013). Other studies have concluded that lower cognitive performance in patients with 
kidney disease may be from deficient blood flow to the brain secondary to albuminuria 
(Sacre et al., 2019). Some researchers infer that because of the similar vasculature of the 
kidney and brain, the two should be studied as a direct and unified pathway. However, 
other researchers suggest the two organs are indirectly linked such that if the kidneys are 
not properly functioning, there is a decreased blood flow rate to the brain, resulting in 




Those with Albuminuria scored worse on cognitive testing, especially in memory 
and processing speed (Sacre et al., 2019; Passos et al., 2018). Albuminuria was deemed a 
dementia risk factor due to its prevalence in those who performed less well on cognitive 
tests. (Deckers et al., 2017; Wei et al., 2017). Albumin levels were almost double in those 
with cognitive impairment than those without. Cerebrovascular lesions from CKD can 
correlate to the higher risk of cognitive disorder development (Wei et al., 2017). 
Breakdown of the blood brain barrier is also a concern with albuminuria due to its 
association with vascular endothelial function. If that occurs, cognitive changes may be a 
result along with white matter changes which can be noted on a brain MRI (Burns et al., 
2018).  
 
Knowledge Gap and Aims 
There are two major knowledge gaps: the relationship between kidney and 
cognitive function and why cognitive processing is affected by kidney disease in T2DM. 
By keeping focus on one population, T2DM, and researching their kidney and cognitive 
functioning, answers may derive. The connection of the brain and the kidney will be 
investigated through kidney biomarkers, specifically albumin, and cognitive domains 
with a focus on visual spatial, working memory, verbal memory and scanning and 
tracking composites of the MSLS. Finding a relationship will help fill knowledge gaps 
where kidney health directly impacts cognitive function in an at risk community T2DM. 
The general focus for this research is to identify whether or not kidney function in T2DM 
relates to their cognitive performance. Specifically, the hope is to determine if 
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Maine- Syracuse Longitudinal Study 
 For this research, the Maine-Syracuse Longitudinal Study (MSLS) provided the 
data and the cognitive domains. The domains of interest include composites of working 
memory, scanning and tracking, verbal memory and executive function.  
The Maine- Syracuse Longitudinal Study (MSLS) is a study of aging, 
cardiovascular disease, and cognitive performance. Dr. Merrill F. Elias and Dr. David H. 
P. Streeten began the study in 1974 with a focus on hypertension and cognitive 
performance by collecting data with medical examination, cognitive test batteries and 
questionnaires from participants in central New York. Since 1976, the MSLS has been a 
part of the Department of Psychology at the University of Maine with co-directors Dr. 
Elias and Dr. Michael Robbins. Dr. Fayeza Ahmed has been a part of the MSLS team as 
an associate director since 2018 (Elias, 2016).  
 
Participants 
 The MSLS archive holds a collection of data from thousands of individuals from 
Central New York from when they began the study, at any age above 18. If participants 
chose to keep participating, data collection continued through their adult years (Elias 
2016). The MSLS is a very useful tool when studying cognitive function because it has 
data on individuals as they age through multiple data collections. An individual's 




 There were seven waves of data collection making up a rich database for cross-
sectional and longitudinal analyses. There are over 2000 community participants, of 
whom over 1000 provided longitudinal data. The last two waves of MSLS, waves 6 and 
7, have the most information on diabetes, strokes, physical activity, nutrition, APOE-e4 
genotype, obesity, smoking, and homocysteine and are also the two bigger datasets. For 
this research Wave 6 data was analyzed cross-sectionally and T2DM participants were 
categorized based on serum albumin levels. Because of the limited number of T2DM 




Figure 2: MSLS seven waves.  
This figure represents the seven waves of data collection for MSLS. On the left side of the figure there are 
sections labeled C1 to C5 and those stand for the recruitment cohorts, so the time that community 
participants were recruited to participate in the study. The Ws on the top in bold stand for the different 
waves, there were seven and correspond with funding periods from NIH. The Es represent the examination 
number for a given cohort and given wave. 
 
Covariates and Measurements  
With the specific aim of this research being finding evidence to support 
albuminuria as a risk factor for poorer cognitive performance in T2DM, variables were 
separated into predictor variables, outcome variables, and covariates.   
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Outcome variables were composite indices of cognitive function: i.e., Working 
Memory, Visual Spatial Organization, Executive Function, Scanning and Tracking, and 
Verbal Memory, determined through factor analysis (Elias et al., 2006). Each of the 
composites had specific cognitive measures to determine performance (Figure 2) and for 
each composite higher values indicate better performance. For Scanning and Tracking, 
cognitive measures included the Trail Making Test, parts A and B, digital symbol 
substitution, and symbol search. The Verbal Memory composite included logical memory 
(immediate and delayed recall) and the Hopkins Verbal Learning Test. The  Visual 
Spatial Organization composite included measures of visual reproductions (immediate 
and delayed recall), matrix reasoning, block design, object assembly, and Hooper visual 
organization. Working memory was assessed through measures of digit span forward and 
backward, letter-number sequence, and controlled oral word associations (Figure 2). 
Executive function was assessed through clock drawing tasks and Controlled Oral Word 




Figure 3: MSLS Outline of cognitive composites. 
Outline of the cognitive composites used for MSLS data analyses. For this research, the composites of 
interest are highlighted in the gold box. The measures used to determine cognitive function are listed under 
each composite. 
 
Demographic variables used in the study were age (in years), education (in years), 
gender (0 = male; 1 = female) and ethnicity (African American = 1; other = 0).  The 
biomarkers of kidney function, estimated GFR, creatinine (mg/dl) and albumin (G/DL), 
were the predictor variables. The eGFR was estimated using the four-variable (serum 
creatinine, age, sex, ethnicity) Modification of Diet in Renal Disease (MDRD) study 
formula (mL/min/1.73 m2 ) (Levey et al, 1999; Rule, et al., 2004).     
  The covariates included hypertension, body mass index (BMI) (kg/m2), and low 
density lipid (LDL) cholesterol (mg/dl). Hypertension was defined as systolic blood 
pressure > 140 mmHg and/or diastolic blood pressure > 90 mmHg and/or anti-
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hypertensive medications, and coded as 0 = no and 1 = yes. Systolic and diastolic blood 
pressure values were averaged from 5 assessments each while recumbent, standing and 
sitting.  
 Those variables were chosen because they have a known effect on either 
cognitive ability or diabetes and kidney function. 
 
Test Procedures at Wave 6 
Participants were mailed psychological inventories to complete and bring to their 
examination at the study center. They were admitted to the study center following a fast 
from midnight. A blood sample was drawn by a licensed phlebotomist, and a light 
breakfast, including decaffeinated coffee or tea, was served. Breakfast was followed by a 
physical examination, including a detailed medical history, measurement of weight and 
height, and blood pressure assessment. This was followed by administration of the 
cognitive test battery by a psychological examiner  (Elias et al., 2006). 
The fasting blood samples were collected in serum separator tubes (gel and clot 
activator) for serum determinations. All blood samples were immediately sent on ice to 
Centrex Clinical Laboratories, Syracuse, NY, for processing and determination of the 
lipid profile (including Low Density Lipid (LDL) cholesterol), glucose, and creatinine. 
Serum creatinine was determined using a 2-point rate test type on a Johnson and Johnson 
Vitros Instrument. Coefficients of variation for these procedures were less than 5.0%. 
Serum samples used for determination of albumin were stored at - 40°C prior to batch 




Statistical Analysis  
Descriptive statistics were examined for all of the variables used in the study. In 
order to assess bivariate associations between variables, correlation coefficients were 
computed comparing demographic information, predictor variables, covariates, and 
outcome variables. Where bivariate correlations between predictor and outcome variables 
were statistically significant, a series of hierarchical multiple regression models was used 
to determine whether the significant associations remained with adjustment for 










Table 1: Demographic Information 
 
Notes: N = 121 
a BMI = Body Mass Index 
 
 
There were a total of 121 T2DM participants in this analysis. Demographic information is 
presented in Table 1. The minimum age recorded was 38 and the maximum was 93, the average 
being 64.04 and median being 65. There were 58 males and 63 females. For ethnicity, 100 
participants identified as “Other” and 21 identified as “African American”. The mean education, 
in years, was 13.7 with 8 being the minimum and 20 being the maximum. Albumin levels were in 
the normal range for all participants. The minimum level of albumin recorded was 3.30 and the 
maximum recorded was 5.00, averaging at 4.14. Creatinine ranged from 53 to 203, with a mean 
 Frequency Minimum Maximum Mean Standard 
Deviation  







    
Ethnicity 





    
Education (in years)  8 20 13.74 2.67 
Albumin  3.30 5.00 4.145 .30 





33 137 75.41 22.53 
a BMI  20 66 33.27 7.44 







    
GFR  33 137 75.41 22.53 
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of 92.01 and standard deviation of 30.42. GFR ranged from 33 to 137, with a mean of 75.4 and 
standard deviation of 22.5. BMI had a minimum of 20 and maximum of 66 while averaging at 
33.27. LDL Cholesterol ranged from 95 to 367 with a mean of 189.80.  Out of the 121 
participants, only 17 did not have a diagnosis of hypertension.   
 
Bivariate Correlations 
Four separate bivariate correlation analyses were run in this study. One analysis related 
demographic variables, predictor variables and covariates (Table 2). Predictor variables 
had significant correlations with several of the demographic variables and covariates. 
Albumin was significantly and negatively correlated with gender (males), ethnicity(non-
African Americans), and lower BMI. Creatinine was significantly and negatively 
correlated with gender and positively correlated with hypertension. GFR was 
significantly and negatively correlated with creatinine, gender, and age. 
There were also significant correlations among demographics variables and 
covariates. Age showed significant negative correlations with ethnicity, BMI, and 
cholesterol while holding a significant positive correlation with diagnosed hypertension. 
Gender had a significant positive correlation with cholesterol, and ethnicity had 
significant positive correlations with education and BMI.  
The second bivariate correlation analysis was between the demographic and 
cognitive outcome variables (Table 3).  Each of the five cognitive outcome variables was 
significantly and positively correlated with years of education.  Visual Spatial 
Organization was also significantly but negatively correlated with  age, gender and 
ethnicity. Verbal Memory was significantly and negatively correlated with age only. 
Working Memory was significantly and negatively correlated with ethnicity only. 
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Scanning Tacking and Executive function were both significantly and negatively 
correlated to age and ethnicity. 
The third bivariate correlation analysis related predictor variables to covariates 
(Table 4). Albumin was significantly and negatively correlated to BMI. Creatinine and 
GFR were strongly negatively correlated and, respectively, held significant positive and 
negative correlations to diagnosed hypertension.  
 The last bivariate correlation analysis related predictor variables to the cognitive 
outcome variables (Table 5). Neither Verbal Memory nor Scanning Tracking showed 
significance in relation to any of the predictor variables. Visual Spatial Organization was 
significantly and positively correlated to albumin and GFR.  Both Working Memory and 
Executive Function showed significant negative correlations to creatinine, but positive 
correlations to GFR. 
 
Table 2 
Pearson Correlation Coefficients: Demographic Variables with Predictors and Covariates  
Notes: N = 121 for all variables.  
a BMI = Body Mass Index, measured by kg/m2 
b Cholesterol was measured by mg/dL 
c Hypertension was measured by diagnosis 




 Albumin Creatinine  GFR Age Gender Ethnicity Education BMI Cholesterol Hypertension 
Albumin  -.12 .15 -.06 -.21* -.20* .08 -.25** .09 -.03 
Creatinine   -.83** .09 -.34** .09 .05 .10 -.14 .19* 
GFR    -.31** -.02 .09 -.09 -.05 .13 -.23* 
Age     .04 -.33** -.08 -.31** -.22* .18* 
Gender      .18 -.09 .11 .19* -.06 
Ethnicity       -.19* .43** .01 .06 
Education        .02 -.12 -.10 
BMI a         -.01 .13 
Cholesterol 
b 
         -.13 
Hypertensi
on c 




Pearson Correlation Coefficients: Demographic Variables with Cognitive Variables 






Age   -.48** -.32** -.12 -.44** -.31** 
Gender -.25** -.05 -.08 -.09 -.17 
Ethnicity -.25** -.09 -.29** -.27** -.30** 
Education .43** .30** .27** .40** .34** 




Pearson Correlation Coefficients: Predictors with Covariates  
 Albumin Creatinine GFR BMI Cholesterol Hypertension 
Albumin  -.12 .15 -.25** .09 -.03 
Creatinine    -.83** .10 -.14 .19* 
GFR    -.05 .13 -.23* 
BMI     -.11 -.13 
Cholesterol      .13 
Hypertension       




Pearson Correlation Coefficients: Predictor with Cognitive Variables  
*p < .05; ** p< .01 
  
Hierarchical Multiple Regressions 
There were six hierarchical regression models used for this research, with the 
cognitive variables that were significantly correlated with kidney function variables used 
separately as an  outcome variable in each model. For the first four hierarchical models 
(Tables 6-9), demographic variables were entered in the first step of the model. The 










Albumin  -.12 .15 .21* .05 .09 .15 .09 
Creatinine   -.83** -.08 -.04 -.19* -.14 -.22* 
GFR    .22* .09 .18* .17 .25** 
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second step added either albumin values or GFR values. The first model related albumin 
to the Visual Spatial Organization domain, but albumin was not significantly associated 
with visual spatial scores after accounting for variance from the demographic variables 
(Table 6). The next three regression models related GFR to Visual Spatial Organization, 
Working Memory, and Executive Function, respectively. GFR remained a significant 
predictor for the domains of Working Memory (β=.18, t=2.03 (114), p<.05) and 
Executive Function (β=.19, t=2.42 (114), p<.05), but not for Visual Spatial Organization 
(Tables 7-9). In order to examine whether other important health variables (BMI, 
cholesterol, and hypertension) influenced the relationship we found between GFR and the 
two cognitive domains (Working Memory and Executive Function), two additional 
hierarchical regression analyses were run with demographic variables entered into the 
first step, health variables entered into the second step, and GFR added to the last step 
(Tables 10-11).  For Working Memory, GFR continued to account for significant 
variance (β=.21, t= 2.31 (111), p<.05; Table 10). For Executive Function, GFR also 
continued to account for significant variance (β=.19, t=2.38 (111), p<.05: Table 11).  
 Most of the correlations have relatively small strengths of association, but age and 
education did show strong associations, particularly to the Visual Spatial (R2 =.23, R2 
=.18) and scanning tracking (R2 =.19, R2 = .16) cognitive domains. Rounding, age and 
education had about 20% common variance with these cognitive variables (Table 3). For 
the adjusted R2 in the hierarchical multiple regression of executive function, covariates, 
and GFR, the model is accounting for one-third (adjusted R2 = .33) of the variability in 






Hierarchical Multiple Regression of Visual Spatial and Albumin 
 
Note: N = 120. Step 1: R = .73. R2 = .530. Adjusted R2 = .513. standard error of estimate = .80. p < 0.01. 
Step 2: R = .730. R2 = .533. Adjusted R2 = .512. standard error of estimate = .80. p < 0.01. 
Table 7 
Hierarchical Multiple Regression of Visual Spatial and GFR 





































Note: N = 120. Step 1: R = .73. R2 = .530. Adjusted R2 = .51. standard error of estimate = .80. p < .05. Step 
2: R = .74. R2 = .54. Adjusted R2 = .52. standard error of estimate = .79. p < .05.  
 
Table 8 
Hierarchical Multiple Regression of Working Memory and GFR 





































Note: N = 120. Step 1: R = .40. R2 = .160. Adjusted R2 = .131. standard error of estimate = .97. p < 0.05. 




Hierarchical Multiple Regression of Executive Function and GFR 
 Step b t p 












































































Note: N = 120. Step 1: R = .57. R2 = .32 Adjusted R2 = .295. standard error of estimate = .89. p < 0.05. Step 






Table 10  
Hierarchical Multiple Regression of Working Memory, Covariates, and GFR  













































































Note: N = 120. Step 1: R = .400. R2 = .16. Adjusted R2 = .13. standard error of estimate = .97. p < 0.05. 
Step 2: R = .42. R2 = .18. Adjusted R2 = .13. standard error of estimate = .97. p < .05. Step 3: R = .46. R2 = 
.22. Adjusted R2 = .16. standard error of estimate = .95. p < .05.  
 
Table 11  
Hierarchical Multiple Regression of Executive Function, Covariates, and GFR  












































































Note: N = 120. Step 1: R = .57. R2 = .32. Adjusted R2 = .30. standard error of estimate = .89. p < .01. Step 
2: R = .59. R2 = .344. Adjusted R2 = .30. standard error of estimate = .88. p < .01. Step 3: R = .61. R2 = .38. 



















The relationship between kidney and cognitive function, specifically why 
cognitive processing is affected by kidney disease in T2DM, is an ongoing focus in 
research. Typically, the variables of interest are creatinine and GFR since they are a 
clearer depiction of proper kidney function and common in routine testing (Albuminuria). 
The research in this study, however, focused on albumin because of its known effect on 
brain function relative to kidney function (Bae et al., 2013).  Albumin is a protein in the 
liver that functions to transport hormones and fluids through the bloodstream. 
Albuminuria is associated with obesity and metabolic syndrome, and can eventually lead 
to insulin resistance. That raises concern because insulin resistance is a leading cause of 
T2DM. In conjunction with other risk factors such as obesity, hypertension, or high 
cholesterol, albuminuria can cause significant decline in cognitive function (Deckers et 
al., 2017; Wei et al., 2017). Albumin levels were found to be significantly higher in those 
with severe cognitive impairment (Wei et al., 2017).  With evidence from previous 
literature review articles, the next step in evaluating kidney and cognitive function in 
regards to albuminuria was to research a specific group of people. In this case, T2DM 
participants from the MSLS dataset were chosen to analyze the association between 
albuminuria and cognitive function. This is an important area of research due to the 
prevalence of individuals affected by T2DM and CKD. Due to the increasing life span of 
the affected population, the T2DM and cognitive dysfunction relationship could pose a 
public health crisis in the near future (Moheet et al., 2015).  
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There are many direct relationships between organ systems, such as circulatory 
and respiratory and many indirect ones such as the urinary and nervous, which need to be 
researched more. The general aim of this study was to find a relationship between kidney 
and cognitive function in T2DM, specifically aiming to determine albuminuria as a risk 
factor cognitive decline. As more information is gathered on kidney biomarker function, 
further research can delve into proper treatment for these conditions when diagnosed 
concurrently.  
To investigate the general and specific aims of this study, bivariate correlation 
and hierarchical multiple regressions were conducted from the MSLS dataset. The MSLS 
dataset provided information on kidney information, cognitive function, diabetes, strokes, 
physical activity, nutrition, APOE-e4 genotype, obesity, smoking, and homocysteine on 
each of the participants in the last two waves of the dataset. Also, being able to control 
for T2DM while comparing kidney and cognitive function allowed for a specific aim.  
Notably, there were no cases of albuminuria. Thus, the specific aim for this study 
was impacted, as there was a restricted range of albumin values. Albuminuria is an 
increase in albumin in urine and a normal range falls between 3.4 to 5.4 g/dL (“Albumin 
(Blood”), n.d., & “What is albuminuria”, n.d.). The participants had a range between 3.3 
and 5.0, falling perfectly within normal limits (Table 1). However, the investigation with 
albumin was not ceased after this information was noted. Rather, bivariate correlation 
coefficients were computed to relate the distribution of albumin values to cognitive 
performance. Albumin values were significantly correlated to performance in the visual 
spatial cognitive domain only (Table 5), with higher albumin values relating to higher 
cognitive scores. Therefore, to further investigate this association, a hierarchical linear 
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regression analysis was conducted to evaluate the variance in Visual Spatial Organization 
scores that was accounted for by albumin, above and beyond demographic variables. 
Albumin did not remain a significant predictor in this model (Table 6).  
Because GFR was so highly correlated with creatinine (r = -.84), its major 
constituent variable, it was the significant correlations of GFR with the cognitive 
domains of visual spatial, working memory and executive function that were followed up 
with hierarchical multiple regression analyses. For two of these cognitive domains, 
working memory and executive function, GFR remained a significant predictor with 
adjustment for the demographic variables (Table 7-9) as well as for the influence of other 
health variables (BMI cholesterol, and hypertension; Tables 10-11).  
Compared to literature review articles about kidney function, the results in this 
research shared similar results. Zammit and colleagues compared cognitive function in 
older adults with diagnosed CKD. In their study and this research, GFR did not show 
significance when correlated with visuospatial abilities, but showed significance to 
working memory and executive function. The results are consistent with the ones above, 
but the difference is that the article did not control for diabetes. (Zammit et alk., 2017). 
Another study that compared cognitive function and CKD resulted in a relationship 
between poor executive function and low GFR (Silinin et al., 2011). Executive function 
was also deemed impaired when CKD patients were compared to a similar yet healthy 
population, but stated hemodialysis served as improvement for that observation (Murthy 
et al., 2020). A study that solely focused on diagnosed diabetes mellitus individuals 
yielded claims that executive function is impaired with the diagnoses (Thabit et al., 
2012). There are not many credible sources to support both CKD and T2DM in regards to 
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working memory and executive function cognitive domains. Thus, this research is one of 
very few that relate the two conditions together. 
As mentioned previously, this study included physical health covariates of BMI, 
cholesterol, and hypertension due to their known relationship with both CKD and T2DM. 
BMI was significantly correlated with albumin, age, ethnicity, and education. Cholesterol 
was associated with age and gender. Hypertension held significance with age, creatinine, 
and GFR.  
 BMI was included as a covariate to reflect obesity, a known impact on T2DM. If 
a BMI is recorded as 30.0 or higher, it falls within the obesity range (Nuttall., 2015). The 
average for the participant group was just over 33.0 (Table 1).  
Hypertension was a useful covariate to include because it often is the result of 
insulin resistance. The chronic increase in blood pressure, hypertension, disturbs the 
normal uptake of glucose and insulin delivered throughout the body, leading to 
cardiovascular issues, diabetic issues, and kidney impairment (Salvetti et al., 1993). From 
the vasoconstriction produced by hypertension, blood flow is reduced, leading to 
weakness throughout the body. The kidneys are in an extremely vascular area in the 
body, so any weakening in the blood vessels lead to significant decline of proper function 
or impairment (“High Blood Pressure & Kidney Disease,” n.d.). Thus, they are unable to 
properly excrete waste, which leads to the significant correlations with hypertension and 
creatinine and GFR. Cholesterol is also a known risk factor for cardiovascular disease 
because it is known to be related to insulin resistance. Insulin resistance decreases 
cholesterol absorption while increasing cholesterol synthesis (Gylling et al., 2010).  
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Strengths, Limitations and Future Directions 
 Several limitations occurred throughout the process of this study. One limitation 
was that the impact of lifestyle factors was not analyzed. However, that gives a clear 
direction for what should be included in future studies using this database. The database 
did not include a large sample of T2DM, just over 100 participants, which is on the 
smaller end of sample sizes for statistical power. Another limitation is that the dataset 
was not very diverse, the option for ethnicity was either “African American” or “Other”.  
 Despite the limitations, this research holds a considerable amount of strengths. 
Because these analyses were done on a dataset that was completed years ago, variables 
were chosen purely based on interest. There was no worry of data collection and the aims 
were chosen based on the given information. With that, more advanced statistical 
analyses were completed. Thus, an explicit aim was used to answer specific questions, 
leaving less room for error, ambiguity, and general claims. The size of the sample in the 
datasets are quite large, which allowed for the ability to only consider T2DM participants 
to specifically look for cognitive changes. Also, the participants were community based 
and reached a large population of individuals in terms of education, ethnicity, and 
education. Overall, the strength that was the most beneficial is the amount of cognitive 
domains and neurocognitive tests that were used to collect the data from the participants, 
allowing for a comprehensive view of cognitive function.  
 In the future, I would suggest a larger sample size of participants with T2DM and 
diagnosed albuminuria to investigate the original aim of this study. There, albumin could 
be investigated more thoroughly to determine whether it is a credible risk factor for 
cognitive decline. Another recommendation would be to set the population to be 
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participants with albuminuria and participants without and compare in terms of kidney 
and cognitive function. With those additions and incorporation of lifestyle factors that 
affect cognition, the results produced may be stronger and could lead to albuminuria 
being a risk factor and more evidence to support a healthier lifestyle.  
 
Conclusions 
 Overall, this study supports a relationship between kidney and cognitive function 
in T2DM. Although results did not support the original claim of albuminuria being a risk 
factor for poorer cognitive performance, GFR was significantly associated with compared 
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